Corneal Implants Market Size & Share 2022 to 2030
Market Size by Tissue (Human Donor, Artificial Cornea), by Transplant (Anterior Lamellar Keratoplasty, Endothelial Lamellar Keratoplasty), by Condition (Fungal Keratitis, Fuchs Dystrophy, Keratoconus), by End Use & Forecast.
Report ID: GMI1227
|
Published Date: October 2022
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Corneal Implants Market Size
Corneal Implants Market size exceeded a valuation of over USD 320 million in 2021 and is projected to exhibit a 7% CAGR between 2022 and 2030. The growing prevalence of eye diseases across the globe is among the leading factors propelling the industry demand.
Eye conditions such as ocular hypertension and diabetic retinopathy have become significantly prevalent in recent years. Besides, the increasing burden of chronic diseases, such as hypertension and diabetes, has further contributed to several eye disorders, such as glaucoma, which is slated to transform the market dynamics.
Limited availability of tissue donors to impede the corneal implants market progress
Although corneal implantation is a safe procedure, it involves a number of risks, including eye infection, swelling of the cornea, pressure within the eyeball, and rejection of donor cornea, which may hamper industry share. In addition, the limited availability of cornea tissues due to a shortage of donors may further emerge as a major growth restraining factor in the forthcoming years.
Corneal Implants Market Analysis
Corneal implants market from human donor tissue segment recorded a valuation of over USD 320 million in 2021. The segmental gains can be attributed to the rising awareness about corneal transplantation and eye tissue donation techniques. The extensive usage of non-optical grade corneas for therapeutic purposes has resulted in an upsurge in the utilization of donor corneas. Hence, taking note of these scenarios, the industry is set to register a lucrative growth.
Corneal implants market from anterior lamellar keratoplasty (ALK) segment is predicted to depict over 7.5% CAGR through 2030. The increasing prevalence of several eye diseases and the subsequent surge in the number of anterior lamellar keratoplasty procedures are the major factors positively influencing segment expansion. The rising popularity of minimally invasive procedures, coupled with the fewer postoperative and intraoperative complications associated with the transplant technique, will increase segment share.
Corneal implants market from keratoconus segment is predicted to reach USD 150 million by 2030. Keratoconus is a common eye disease that affects the structure of the cornea and often results in loss of vision. The increased cognizance of corneal transplantation as an effective procedure to restore sight in those with the given condition will accelerate business trends. The inability of keratoconic corneas to handle ultraviolet light-induced oxidative stress and the expanding aging population may further propel the market size.
The hospitals segment is set to surpass USD 245 million by 2030. Hospital settings have the availability of robust healthcare infrastructure, emergency facilities, and skilled healthcare professionals, ensuring better patient outcomes. The presence of advanced medical equipment across these establishments translates into an increasing number of patient footfalls, thus augmenting the industry landscape.
North America corneal implants market was worth over USD 190 million in 2021. This is credited to the expanding geriatric population base and the greater susceptibility of aging people to several chronic ailments, such as diabetes. Diabetic people are more prone to developing eye diseases that lead to vision loss. National Eye Institute estimates suggest that over 30,000 Americans undergo corneal transplants to replace injured and diseased corneas, creating numerous growth opportunities for the regional industry.
Corneal Implants Market Share
Leading companies in the corneal implants industry include
These players are focusing on leveraging cutting-edge technologies to develop advanced products to serve the increasingly expanding consumer base.
For instance, in January 2022, Microkpro declared that their MIOK Keratoprosthetics had received a regulatory nod from NMPA, the Chinese regulator of drugs and medical devices. MIOK is the world's first-ever artificial cornea approved so far. It requires no co-implantation of donor corneas and may help the company attract a significant number of customers.
Impact of COVID-19 Pandemic
The corneal implants industry suffered a considerable setback due to the COVID-19 pandemic. The strict lockdown mandates imposed by the local and national authorities limited patients' hospital visits for non-essential treatments, especially during the first half of 2020. Ophthalmic procedures, including keratoplasty and sight-restoring surgeries, were put under elective surgical procedures that can be put on hold, further hampering the industry's revenue. Moreover, long waiting lists and a shortage of donors continued to stress the market outlook post-pandemic.
The corneal implants market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2030 for the following segments:
Click here to Buy Section of this Report
By Tissue Type
By Transplant Type
By Condition
By End-use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →